The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition - Annals of Oncology
MuTILs: explainable, multiresolution computational scoring of Tumor-Infiltrating Lymphocytes in breast carcinomas using clinical guidelines | medRxiv
Clinical relevance of host immunity in breast cancer: from TILs to the clinic | Nature Reviews Clinical Oncology
Evaluating the prognostic significance of tumor-infiltrating lymphocyt | CMAR
Applying the proposed standardized methodology to evaluate tumor... | Download Scientific Diagram
Immune Modulation May Aid Some Breast Cancer Subtypes - The ASCO Post
The Prognostic Role of Tumor-infiltrating CD4 and CD8 T Lymphocytes in Breast Cancer | Anticancer Research
Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers | Diagnostic Pathology | Full Text
The prognostic significance of tumor-infiltrating lymphocytes assessment with hematoxylin and eosin sections in resected primary lung adenocarcinoma | PLOS ONE
Prediction of Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer by Subtype Using Tumor-infiltrating Lymphocytes | Anticancer Research
Evaluating the prognostic significance of tumor-infiltrating lymphocyt | CMAR
Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast | Modern Pathology
Why pathologists and oncologists should know about tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer: an Australian experience of 139 cases - Pathology
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 - ScienceDirect
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I–III patients treated with standard therapy - European Journal of
Tumor-infiltrating lymphocytes and PD-L1 in breast cancer (and, what happened to medullary carcinoma?) - Diagnostic Histopathology
Frontiers | Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions
Relationship Between the Neutrophil to Lymphocyte Ratio, Stromal Tumor-infiltrating Lymphocytes, and the Prognosis and Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer - Clinical Breast Cancer
Figure 3 from The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. | Semantic Scholar
Tumor infiltrating lymphocytes in early breast cancer - The Breast
Prognostic significance of tumour‑infiltrating lymphocytes for oestrogen receptor‑negative breast cancer without lymph node metastasis
